ImmunologybioRxivPreprint
T cell-specific loss of IRF1 results in defective CD8 T cell activation and antitumor immunity
Lulu Shao, Hridesh Banerjee, Ecem Ünal…·Saumendra N. Sarkar
This study shows that T cell-specific loss of IRF1 impairs CD8 T cell activation and antitumor immunity, despite normal cytotoxic T cell numbers.
DOI 10.64898/2026.05.14.725206